Occurrence of mixed populations of influenza A viruses that can be maintained through transmission in a single host and potential for reassortment

Journal of Clinical Microbiology

Volumn 48, Issue 2, 2010, Pages 369-374

  Furuse, Yuki ^a   Suzuki, Akira ^a   Kishi, Makiko ^a   Nukiwa, Nao ^a   Shimizu, Midori ^a   Sawayama, Rumi ^a   Fuji, Naoko ^a   Oshitani, Hitoshi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE;

ANIMAL CELL; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; GENETIC REASSORTMENT; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MAJOR CLINICAL STUDY; MICROBIAL POPULATION DYNAMICS; MIXED INFECTION; NONHUMAN; PHYLOGENETIC TREE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VIRUS CELL INTERACTION; VIRUS CULTURE; VIRUS TRANSMISSION;

AMANTADINE; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CLONING, MOLECULAR; DNA FINGERPRINTING; DOGS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; NASOPHARYNX; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REASSORTANT VIRUSES; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRUS CULTIVATION;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 75649084537     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01795-09     Document Type: Article

References (25)

1. Abed, Y., N. Goyette, and G. Boivin. 2005. Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations. Antimicrob. Agents Chemother. 49:556-559.
2. Appleyard, G. 1977. Amantadine-resistance as a genetic marker for influenza viruses. J. Gen. Virol. 36:249-255.
3. Bright, R. A., M.-J. Medina, X. Xu, G. Perez-Oronoz, T. R. Wallis, X. M. Davis, L. Povinelli, N. J. Cox, and A. I. Klimov. 2005. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 366:1175-1181.
4. Centers for Disease Control and Prevention. 2009, posting date. International co-circulation of novel and seasonal influenza. Centers for Disease Control and Prevention, Atlanta, GA.
5. Deyde, V. M., X. Xu, R. A. Bright, M. Shaw, C. B. Smith, Y. Zhang, Y. Shu, L. V. Gubareva, N. J. Cox, and A. I. Klimov. 2007. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J. Infect. Dis. 196:249-257.
6. Falchi, A., L. Varesi, C. Arena, N. Leveque, F. Renois, T. Blanchon, J. P. Amoros, and L. Andreoletti. 2009. Co-circulation of two genetically distinct sub-groups of A/H3N2 influenza strains during the 2006-2007 epidemic season in Corsica Island, France. J. Clin. Virol. 45:265-268.
7. Fitch, W. M., R. M. Bush, C. A. Bender, and N. J. Cox. 1997. Long term trends in the evolution of H(3) HA1 human influenza type A. Proc. Natl. Acad. Sci. U. S. A. 94:7712-7718.
8. Furuse, Y., A. Suzuki, T. Kamigaki, M. Shimizu, N. Fuji, and H. Oshitani. 2009. Reversion of influenza A (H3N2) virus from amantadine resistant to amantadine sensitive by further reassortment in Japan during the 2006-to-2007 influenza season. J. Clin. Microbiol. 47:841-844.
9. Ghedin, E., A. Fitch, A. Boyne, S. Griesemer, J. Depasse, J. Bera, X. Zhang, R. A. Halpin, M. Smit, L. Jennings, K. St George, E. C. Holmes, and D. J. Spiro. 2009. Mixed infection and the genesis of influenza diversity. J. Virol. 83:8832-8841.
10. Hay, A. J., A. J. Wolstenholme, J. J. Skehel, and M. H. Smith. 1985. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 4:3021-3024.
11. Hayden, F. G., and A. J. Hay. 1992. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr. Top. Microbiol. Immunol. 176:119-130.
12. Hayden, F. G., S. J. Sperber, R. B. Belshe, R. D. Clover, A. J. Hay, and S. Pyke. 1991. Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine. Antimicrob. Agents Chemother. 35:1741-1747.
13. Hoffmann, E., J. Stech, Y. Guan, R. G. Webster, and D. R. Perez. 2001. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 146:2275-2289.
14. Kawaoka, Y., S. Krauss, and R. G. Webster. 1989. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J. Virol. 63:4603-4608.
15. Kumar, S., M. Nei, J. Dudley, and K. Tamura. 2008. MEGA: a biologistcentric software for evolutionary analysis of DNA and protein sequences. Brief. Bioinform. 9:299-306.
16. Lackenby, A., J. Democratis, M. M. Siqueira, and M. C. Zambon. 2008. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies. Antivir. Ther. 13:809-820.
17. Nelson, M. I., L. Edelman, D. J. Spiro, A. R. Boyne, J. Bera, R. Halpin, E. Ghedin, M. A. Miller, L. Simonsen, C. Viboud, and E. C. Holmes. 2008. Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United States. PLoS Pathog. 4:e1000133.
18. Pinto, L. H., L. J. Holsinger, and R. A. Lamb. 1992. Influenza virus M2 protein has ion channel activity. Cell 69:517-528.
19. Saito, R., H. Oshitani, H. Masuda, and H. Suzuki. 2002. Detection of amantadine-resistant influenza A virus strains in nursing homes by PCR-restriction fragment length polymorphism analysis with nasopharyngeal swabs. J. Clin. Microbiol. 40:84-88.
20. Scholtissek, C., W. Rohde, V. Von Hoyningen, and R. Rott. 1978. On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 87:13-20.
21. Shiraishi, K., K. Mitamura, Y. Sakai-Tagawa, H. Goto, N. Sugaya, and Y. Kawaoka. 2003. High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza. J. Infect. Dis. 188:57-61.
22. Simonsen, L., C. Viboud, B. T. Grenfell, J. Dushoff, L. Jennings, M. Smit, C. Macken, M. Hata, J. Gog, M. A. Miller, and E. C. Holmes. 2007. The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Mol. Biol. Evol. 24:1811-1820.
23. Wang, C., K. Takeuchi, L. H. Pinto, and R. A. Lamb. 1993. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J. Virol. 67:5585-5594.
24. Webster, R. G., W. J. Bean, O. T. Gorman, T. M. Chambers, and Y. Kawaoka. 1992. Evolution and ecology of influenza A viruses. Microbiol. Rev. 56:152-179.
25. Zhirnov, O. P., I. V. Vorobjeva, O. A. Saphonova, S. V. Poyarkov, A. V. Ovcharenko, D. Anhlan, and N. A. Malyshev. 2009. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells. J. Clin. Virol. 45:322-333.